Second‐line agents for rheumatoid arthritis

Autor:	Simon Scharf, Nicholas Christophidis
Rok vydání:	1995
Předmět:	Chemotherapy medicine.medical_specialty business.industry medicine.medical_treatment Low dose General Medicine Younger people medicine.disease Surgery Arthritis Rheumatoid Second line Antirheumatic Agents Rheumatoid arthritis Synovitis Humans Medicine business Intensive care medicine Aged
Zdroj:	Medical Journal of Australia. 163:215-218
ISSN:	1326-5377 0025-729X
DOI:	10.5694/j.1326-5377.1995.tb124534.x
Popis:	Second-line agents (disease-modifying agents or slow-acting antirheumatoid drugs) are well established for synovitis that persists despite treatment with non-steroidal anti-inflammatory agents. Indications for their use in the elderly are similar to those in younger people, but the elderly are at higher risk of adverse reactions. Therefore, lower doses, more cautious patient selection and more frequent monitoring for adverse reactions are recommended. Low dose corticosteroids are often effective in the elderly and obviate the need for second-line agents.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9f83ae1ac655091c9dcdfc86a77c90f https://doi.org/10.5694/j.1326-5377.1995.tb124534.x Zobrazit plný text záznamu Plný text